1. Home
  2. TRSG vs AKTX Comparison

TRSG vs AKTX Comparison

Compare TRSG & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRSG
  • AKTX
  • Stock Information
  • Founded
  • TRSG 1996
  • AKTX N/A
  • Country
  • TRSG Singapore
  • AKTX United States
  • Employees
  • TRSG N/A
  • AKTX N/A
  • Industry
  • TRSG
  • AKTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRSG
  • AKTX Health Care
  • Exchange
  • TRSG NYSE
  • AKTX Nasdaq
  • Market Cap
  • TRSG 33.4M
  • AKTX 34.7M
  • IPO Year
  • TRSG 2024
  • AKTX N/A
  • Fundamental
  • Price
  • TRSG $2.05
  • AKTX $1.25
  • Analyst Decision
  • TRSG
  • AKTX
  • Analyst Count
  • TRSG 0
  • AKTX 0
  • Target Price
  • TRSG N/A
  • AKTX N/A
  • AVG Volume (30 Days)
  • TRSG 5.2K
  • AKTX 26.6K
  • Earning Date
  • TRSG 12-31-2024
  • AKTX 02-15-2025
  • Dividend Yield
  • TRSG N/A
  • AKTX N/A
  • EPS Growth
  • TRSG N/A
  • AKTX N/A
  • EPS
  • TRSG N/A
  • AKTX N/A
  • Revenue
  • TRSG $14,441,864.00
  • AKTX N/A
  • Revenue This Year
  • TRSG N/A
  • AKTX N/A
  • Revenue Next Year
  • TRSG N/A
  • AKTX N/A
  • P/E Ratio
  • TRSG N/A
  • AKTX N/A
  • Revenue Growth
  • TRSG 9.34
  • AKTX N/A
  • 52 Week Low
  • TRSG $1.91
  • AKTX $0.90
  • 52 Week High
  • TRSG $11.78
  • AKTX $4.40
  • Technical
  • Relative Strength Index (RSI)
  • TRSG N/A
  • AKTX 51.97
  • Support Level
  • TRSG N/A
  • AKTX $1.10
  • Resistance Level
  • TRSG N/A
  • AKTX $1.39
  • Average True Range (ATR)
  • TRSG 0.00
  • AKTX 0.13
  • MACD
  • TRSG 0.00
  • AKTX -0.00
  • Stochastic Oscillator
  • TRSG 0.00
  • AKTX 61.54

About TRSG TUNGRAY TECHNOLOGIES INC

Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.

About AKTX Akari Therapeutics plc ADS

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Share on Social Networks: